U.S. Stock News

NYSE:CNS
NYSE:CNSCapital Markets

Cohen & Steers (CNS) Looks 12% Above Fair Value As ETF Expansion Story Builds

Cohen & Steers (CNS) has drawn investor attention after a recent stretch of positive share performance, including gains over the past month and past 3 months. This has prompted a closer look at its fundamentals and valuation. See our latest analysis for Cohen & Steers. The recent move in Cohen & Steers’ share price, including a 9.08% 30 day share price return and 22.55% 90 day share price return, sits alongside a 3.59% 1 year total shareholder return and a stronger 3 year total shareholder...
NYSE:ENOV
NYSE:ENOVMedical Equipment

How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing

On 27 June 2026, Enovis Corporation (NYSE: ENOV) was removed from both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, prompting index-tracking funds to rebalance their holdings. This index exclusion could alter Enovis’s investor base and liquidity profile, potentially increasing trading volatility as passive capital adjusts its exposure. We will now examine how Enovis’s removal from the Russell 2000 Defensive indices interacts with its existing growth and margin...
NasdaqCM:SHAZ
NasdaqCM:SHAZIT

SharonAI Holdings (SHAZ) Looks Pricey As $1.6b Raise Fuels AI Buildout

SharonAI Holdings (SHAZ) has closed an oversubscribed US$1.6 billion private placement, funding a six year collaboration with NVIDIA and a planned build out of large scale AI infrastructure and GPU capacity. See our latest analysis for SharonAI Holdings. The latest US$1.6b raise and index inclusions have arrived during a period of sharp momentum for SharonAI Holdings, with a 30 day share price return of 11.64% and a 90 day share price return above 200%. This contrasts with a 3 year total...
NYSE:GFF
NYSE:GFFBuilding

Griffon (GFF) Joins Russell Value Indices Is Its Home Products Story Becoming a Defensive Play?

In late June 2026, Griffon Corporation (NYSE:GFF) was added to several Russell value-oriented indices, including the Russell 2000 Value, Russell Small Cap Comp Value, Russell 2500 Value, Russell 3000 Value, Russell 3000E Value, and the Russell 2000 Value-Defensive Index. This broad inclusion across value-focused benchmarks embeds Griffon more deeply into quant and passive portfolios, potentially altering how investors view its profile within the home and building products space. We’ll now...
NYSE:SSB
NYSE:SSBBanks

The Bull Case For SouthState Bank (SSB) Could Change Following Its Shift Into Russell Defensive Indices

On 27 June 2026, SouthState Bank Corporation (NYSE: SSB) was added to the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, while being removed from the Russell 1000 Dynamic Index. These index changes could influence how SouthState Bank is viewed by institutional investors, potentially shifting its profile toward more defensive and value-oriented mandates. Next, we’ll examine how SouthState’s shift into Russell’s defensive and value-focused indices could shape its...
NasdaqGM:EXAI
NasdaqGM:EXAIBiotechs

AI Drug Discovery Stocks Retail Investors Are Watching After Claude Science

Anthropic’s launch of Claude Science has thrown fresh attention on stocks that sit at the intersection of artificial intelligence and drug discovery, where software meets lab science. For investors watching this theme, the question is which companies might gain most from large pharma and biotech groups exploring AI tools for protein modelling, target identification and faster experiments, and which might struggle if regulation tightens. This article picks out 3 stocks from our AI Powered Drug...
NYSE:ALB
NYSE:ALBChemicals

Is Albemarle’s (ALB) Leaner Lithium Strategy Quietly Rewriting Its Energy Storage Investment Narrative?

Recent commentary highlights how Albemarle has responded to earlier lithium oversupply and softer EV demand by cutting capital expenditure, idling higher‑cost capacity, divesting non‑core assets, and sharpening its focus on energy storage as rising lithium prices are increasingly supported by data‑center battery demand and long‑term policy tailwinds. At the same time, analysts point to improving earnings expectations, operational efficiency gains, debt reduction and progress on key lithium...
NYSE:VICI
NYSE:VICISpecialized REITs

Accenture Stock And Exxon Mobil Offer A Fresh Take On Reliable Dividend Income

With inflation readings mixed across regions, central banks weighing their next moves and growth holding up in several major economies, many investors are looking for income that feels steadier than short term market headlines. That is where Dividend Powerhouses can help. This screener focuses on companies offering more than a 5% yield, with dividends that appear well covered, growing and stable based on the criteria provided. In this article, three of the strongest candidates from the...
NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle Gro (SMG) Rebound Raises The Question Of Whether Its Valuation Is Already Priced In

Scotts Miracle-Gro stock snapshot after recent performance Scotts Miracle-Gro (SMG) has drawn fresh attention after recent share price moves, with the stock last closing at $68.11. Investors are reassessing the lawn and garden supplier using its latest return and earnings figures. See our latest analysis for Scotts Miracle-Gro. Recent trading in Scotts Miracle-Gro reflects building momentum, with a 7-day share price return of 7.28% and a 30-day share price return of 15.44%, set against a...
NYSE:CTS
NYSE:CTSElectronic

Will CTS' (CTS) Insider CEO Promotion and Executive Chair Shift Change Its Leadership Narrative?

CTS Corporation has announced that its Board promoted current COO Pratik Trivedi to Chief Executive Officer and President, effective July 6, 2026, with long-serving CEO Kieran O’Sullivan moving to the Executive Chair role while remaining on the Board. This leadership handover combines internal succession with governance continuity, as Trivedi joins the Board while O’Sullivan stays involved as Executive Chair after 14 years as CEO. We’ll now examine how promoting insider Pratik Trivedi to CEO...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

CECO Environmental (CECO) Is Down 6.1% After Broad Russell Index Removal Has The Bull Case Changed?

In late June 2026, CECO Environmental Corp. was removed from multiple Russell indices, including the Russell 2000 Value, Russell 3000E, and Russell Microcap benchmarks, reducing its presence in several widely tracked market barometers. This broad index removal may alter how passive funds and quantitative investors hold or monitor CECO, potentially shifting its shareholder base and trading profile over time. Next, we’ll examine how CECO’s broad removal from Russell indices could influence its...
NYSE:PVH
NYSE:PVHLuxury

PVH (PVH) Faces EMEA Downgrade Pressure, Is The Stock Still Below Fair Value?

Why PVH’s new credit deal and EMEA concerns matter for the stock PVH (PVH) is back in focus after analysts flagged higher risks tied to its Europe and Middle East exposure, just as the company secured a new long dated credit agreement and refinanced existing debt. See our latest analysis for PVH. PVH’s recent analyst downgrade and EMEA concerns have coincided with a sharp swing in momentum, with the stock’s 30 day share price return down 20.39% even though the year to date share price return...
NYSE:AMP
NYSE:AMPCapital Markets

Ameriprise Financial (AMP) Could Be 15% Undervalued After Russell Index Reshuffle

Index reshuffle puts Ameriprise Financial in the spotlight Ameriprise Financial (AMP) has shifted index footing, dropping from the Russell 1000 Dynamic Index while being added to the Russell 1000 Defensive, Value Defensive, and Growth Defensive indexes, a reshuffle that can influence trading flows. See our latest analysis for Ameriprise Financial. At a share price of $458.76, Ameriprise Financial has a 1 day share price return of 2.68%, while the share price return year to date is down 7.09%...
NYSE:STAG
NYSE:STAGIndustrial REITs

STAG Industrial (STAG) On Russell 1000 Exit And The Case For Undervaluation

Why STAG Industrial Is Back On Investors' Radars STAG Industrial (STAG) has come back into focus after its removal from the Russell 1000 Dynamic Index on June 27, 2026, an index change that can affect institutional ownership and trading activity. For income focused investors, the move raises fresh questions about how to think about STAG Industrial's dividend profile, earnings outlook, and current valuation in light of its recent index exclusion. See our latest analysis for STAG Industrial. At...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Extreme Networks (EXTR) Could Be 11% Overvalued Following Its New Stadium Wi Fi 7 Win

Extreme Networks (EXTR) is back in focus after unveiling Extreme Multi-Beam Wireless for high-density venues and being selected to power Wi-Fi 7 connectivity at the Tennessee Titans’ new Nissan Stadium. See our latest analysis for Extreme Networks. Extreme Networks’ recent product and client announcements come on top of strong share price momentum, with a 22.10% 1-month share price return, 112.96% 3-month share price return and 195% 5-year total shareholder return suggesting interest in the...
NasdaqGM:RDZN
NasdaqGM:RDZNSoftware

Roadzen (RDZN) Stock Faces Wider EPS Loss As Growth Narrative Tested By Q4 Results

Roadzen (NasdaqGM:RDZN) has just posted its FY 2026 fourth-quarter numbers, reporting revenue of about US$16.1 million and a basic EPS loss of US$0.09. Trailing twelve-month revenue came in at roughly US$55.0 million and EPS at a loss of US$0.29. Over recent periods the company has seen quarterly revenue move from US$11.4 million in Q4 FY 2025 to US$16.1 million in Q4 FY 2026. Over the same timeframe, basic EPS shifted from a small loss of US$0.00 to a wider loss of US$0.09. This leaves...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab (GRAB) Analysts Lift Earnings Outlook But What Does It Reveal About Its Profit Trajectory?

In recent weeks, Grab Holdings Limited has attracted increased attention after analysts raised earnings estimates for the current and next fiscal years, citing clearer revenue guidance and stronger profitability in 2025 and Q1 2026. This shift in expectations highlights how scaling superapp and fintech operations across Southeast Asia are sharpening the focus on Grab’s evolving profit profile and valuation framework. We’ll now examine how analysts’ upgraded earnings expectations and...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Completes Freight Spin Off As Separate Public Company Begins Trading

FedEx (NYSE:FDX) has completed the spin-off of its FedEx Freight unit. FedEx Freight is now a separate, publicly traded company with its own business strategy. The newly independent FedEx Freight has released its first stand-alone financial and strategic updates. For FedEx, this move reshapes how its core operations are organized across express, ground and less than truckload freight services. Investors now see FedEx Freight as a focused trucking business, while the remaining FedEx...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Does Array Technologies (ARRY) ESOP Shelf and New Tracker Reveal a Shift in Global Priorities?

Earlier this month, Array Technologies filed a US$202.42 million shelf registration for 26,425,733 common shares tied to an ESOP-related offering and launched its DuraTrack D2S dual-row solar tracker, initially targeting the EMEA market with a first commercial project underway in Spain. The DuraTrack D2S rollout highlights how Array is tailoring its core tracker architecture to complex terrain and two-row layouts that many international utility-scale solar developers prefer. We’ll now...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Joins Multiple Russell Growth Indexes Is Its Biotech Role Being Repriced?

In late June 2026, Relay Therapeutics, Inc. was added to multiple Russell growth benchmarks, including the Russell 3000 Growth, Russell 2000 Growth, Russell 2500 Growth, Russell 3000E Growth, and the Russell Small Cap Comp Growth indexes. This broad-based inclusion across several influential growth indexes can increase Relay Therapeutics’ visibility among institutional investors and index-tracking funds, potentially reshaping how the market views its role within the small- and mid-cap...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Did Broad Russell Index Removal Just Reframe Lumentum Holdings' (LITE) AI-Focused Investment Narrative?

In late June 2026, Lumentum Holdings Inc. (NasdaqGS:LITE) was removed from several major Russell indices and value and growth benchmarks, potentially affecting index-linked ownership and liquidity. This extensive index exclusion contrasts with the company’s recent focus on AI-related optics and governance, highlighted by its June 2026 presentations at the Rome Conference on AI Ethics and Governance. Next, we’ll examine how Lumentum’s broad removal from key Russell indices may alter its...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet (PODD) After Russell Index Inclusion With Fair Value Still In Focus

Insulet (PODD) has just been added to both the Russell 2500 and Russell 2500 Growth indexes, a change that can influence institutional ownership as index funds align their holdings with the new benchmarks. See our latest analysis for Insulet. Insulet’s recent index additions follow a mixed price pattern, with a 7 day share price return of 5.87% and a 30 day share price return of 5.11%. However, the year to date share price return is down 46.15%, while the 1 year total shareholder return is...
NYSE:BAC
NYSE:BACBanks

Bank of America (BAC) Faces SEC Scrutiny After Merrill Lynch Anti Money Laundering Fine

Merrill Lynch, the wealth management arm of Bank of America, has been fined $7.5 million by the SEC for anti money laundering compliance failures. The regulator found that Merrill Lynch did not adequately monitor and report certain suspicious transactions over multiple years. As part of the settlement, Merrill Lynch is required to overhaul aspects of its anti money laundering controls and monitoring systems. For investors following Bank of America (NYSE:BAC), this SEC action adds a fresh...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Ardelyx (ARDX) Faces New Medicare Rules For Xphozah After Court Ruling

U.S. federal appellate court rules that Ardelyx’s Xphozah will be included in Medicare’s ESRD bundled payment system, ending separate reimbursement. The decision resolves a long-running legal dispute over how the drug is treated under Medicare’s payment structure for dialysis care. The ruling affects how dialysis providers are paid for Xphozah and may influence pricing decisions and product positioning for NasdaqGM:ARDX. Ardelyx, the biopharmaceutical company behind Xphozah, focuses on...